Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/252.14
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding > The additional hetero ring is a 1,3 diazine ring
Description: Subject matter wherein the additional hetero ring consists of four carbon atoms and two nitrogens; the nitrogens are in the 1- and 3- positions of the ring.

Sub-classes under this class:

Class Number Class Name Patents
514/252.18 Additional six-membered hetero ring consisting of five ring carbons and one ring nitrogen attached directly or indirectly to the 1,3-diazine by nonionic bonding 329
514/252.19 Five-membered nitrogen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding 312
514/252.2 Oxygen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding 104
514/252.16 Polycyclo ring system having the additional 1,3-diazine ring as one of the cyclos 443
514/252.15 Spiro ring system containing 65

Patents under this class:
1 2 3 4 5 6 7 8 9 10

Patent Number Title Of Patent Date Issued
8703767 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors Apr. 22, 2014
8703771 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor Apr. 22, 2014
8680097 Benzothiophene alkanol piperazine derivatives and their use as antidepressant Mar. 25, 2014
8653093 Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases Feb. 18, 2014
8598162 Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders Dec. 3, 2013
8580790 (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Nov. 12, 2013
8575171 Methods and compositions for treating thyroid-related medical conditions with reduced folates Nov. 5, 2013
8557812 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof Oct. 15, 2013
8557821 Microbiocidal heterocycles Oct. 15, 2013
8546390 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and AIDS Oct. 1, 2013
8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses Oct. 1, 2013
8530465 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof Sep. 10, 2013
8530476 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase Sep. 10, 2013
8518947 (Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Aug. 27, 2013
8513233 Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists Aug. 20, 2013
8507485 Cyclic compound having pyrimidinylalkylthio group Aug. 13, 2013
8486947 Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H.sub.3-receptor ligands Jul. 16, 2013
8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor Jul. 2, 2013
8470826 Episomal fusion gene Jun. 25, 2013
8466156 2-phenyl-4-cyclopropyl-pyrimidine derivatives Jun. 18, 2013
8466155 Pyrimidines Jun. 18, 2013
8461147 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation Jun. 11, 2013
8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes Apr. 30, 2013
8431573 Cyanopyrimidinones Apr. 30, 2013
8420630 Pyrimidine derivatives Apr. 16, 2013
8414918 Stable imatinib compositions Apr. 9, 2013
8415345 Benzene sulfonamide thiazole and oxazole compounds Apr. 9, 2013
8404665 In vivo use of glutathione S-transferase activated nitric oxide donors Mar. 26, 2013
8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis Mar. 19, 2013
8389521 Inhibitors of protein kinases Mar. 5, 2013
8383626 Nitric oxide donors for inducing neurogenesis Feb. 26, 2013
8377921 Compounds and compositions as protein kinase inhibitors Feb. 19, 2013
8343974 Methods and compositions for treating thyroid-related medical conditions with reduced folates Jan. 1, 2013
8318736 HIV inhibiting 5,6-substituted pyrimidines Nov. 27, 2012
8309543 Compositions useful as inhibitors of voltage-gated sodium channels Nov. 13, 2012
8309550 Kinase inhibitors and their use as pharmaceutical agents Nov. 13, 2012
8293745 Use of imatinib to treat liver disorders and viral infections Oct. 23, 2012
8293746 Pyrimidinyl aryl urea derivatives being FGF inhibitors Oct. 23, 2012
8283344 Method of treating inherited severe neutropenia Oct. 9, 2012
8277839 Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof Oct. 2, 2012
8268822 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases Sep. 18, 2012
8268826 Piperazinylpiperidine derivatives as chemokine receptor antagonists Sep. 18, 2012
8263590 Pyrimidine derivatives Sep. 11, 2012
8258130 Pyrimidine hydrazide compounds as PGDS inhibitors Sep. 4, 2012
8258129 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments Sep. 4, 2012
8247411 Sulfonyl amide derivatives for the treatment of abnormal cell growth Aug. 21, 2012
8247419 Methods of identifying and treating individuals exhibiting mutant kit protein Aug. 21, 2012
8217045 Organic compounds Jul. 10, 2012
8202863 Pyrimidine amide compounds as PGDS inhibitors Jun. 19, 2012
8202861 Compositions useful as inhibitors of voltage-gated sodium channels Jun. 19, 2012

1 2 3 4 5 6 7 8 9 10

  Recently Added Patents
Projection screen and projection system having the same
Non-zero rounding and prediction mode selection techniques in video encoding
Systems and/or methods for using air/wind power to charge/re-charge vehicle batteries
Front exterior of an automotive tail lamp
Method of predicting a motion vector for a current block in a current picture
Titanium compounds and complexes as additives in lubricants
Single-chain variable fragment (scFv) able to recognize and bind CD99 human protein
  Randomly Featured Patents
Soluble 2-chloro-2'-deoxyadenosine formulations
Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm using a dendrimer sugar conjugate
Electric incandescent lamp having truncated conical filament and a mirror coating
Insulated concrete wall
Execution of requests in a parallel database system
Method for reduced sulfur dioxide formation in refiner bleaching
Image pixel design to enhance the uniformity of intensity distribution on digital image sensors
System and method for compensating viewer for viewing of designated channel with reduction of telephone charges
Temperature controlled flexible electric heating panel
Video telephone system and terminal device therefor